MTOR and hepatocellular carcinoma: Furthermore, Zhou and colleagues in their investigation approved that in hepatocellular carcinoma cells, fibronectin type III domain-containing protein 5 stimulates autophagy through the AMPK/mTOR signaling pathway, which adds to the chemoresistance to nab-paclitaxel (99).